Both in R&D — Physical & Biological Sciences
Charles River Laboratories International vs Incyte Genomics
Over the past year CRL returned +96.7% and INCY returned +15.8%; their daily moves had a correlation of 0.26.
CRL +96.7% INCY +15.8%Growth of $1, one year, split-adjusted
| Metric | CRL | INCY |
|---|---|---|
| Price | $351.87 | $117.59 |
| Market cap | $16.80B | $23.97B |
| Today | +3.94% | −2.04% |
| 1 month | +13.2% | +3.0% |
| 6 months | +89.8% | +20.6% |
| Year to date | +76.4% | +19.1% |
| 1 year | +95.4% | +25.8% |
| Revenue growth (YoY) | −2.7% | +14.0% |
| Gross margin | 36.2% | 93.0% |
| Net margin | −0.1% | −50.4% |
| P/E (TTM) | — | 59.4× |
| Price / sales | 4.2× | 4.0× |
| Net cash | -$2.43B | $3.82B |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 27.2% |
| Short % of float | 6.0% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).